About Biosyntech
Biosyntech is a company based in Laval (Canada) founded in 1994 was acquired by Piramal Group in June 2010.. Biosyntech has raised $1.4 million across 1 funding round from investors including Piramal Group, ProQuest Investments and Highland Capital Partners. Biosyntech operates in a competitive market with competitors including Augmenix, AmacaThera, QBiotics, MediWound and Ilya Pharma, among others.
- Headquarter Laval, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.4 M (USD)
in 1 rounds
-
Latest Funding Round
$1.4 M (USD), Series A
Jun 01, 2009
-
Investors
Piramal Group
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Piramal Group
(Jun 22, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biosyntech
Biosyntech has successfully raised a total of $1.4M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.4 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $1.4M
-
First Round
First Round
(01 Jun 2009)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2009 | Amount | Series A - Biosyntech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biosyntech
Biosyntech has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Piramal Group, ProQuest Investments and Highland Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investment and entrepreneur support services.
|
Founded Year | Domain | Location | |
|
VC firm focusing on life science sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biosyntech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biosyntech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biosyntech Comparisons
Competitors of Biosyntech
Biosyntech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmenix, AmacaThera, QBiotics, MediWound and Ilya Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hydrogel spacers are provided for prostate cancer radiation therapy.
|
|
| domain | founded_year | HQ Location |
Injectable hydrogel platform developed for therapeutic medical applications.
|
|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| domain | founded_year | HQ Location |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biosyntech
When was Biosyntech founded?
Biosyntech was founded in 1994 and raised its 1st funding round 15 years after it was founded.
Where is Biosyntech located?
Biosyntech is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
Is Biosyntech a funded company?
Biosyntech is a funded company, having raised a total of $1.4M across 1 funding round to date. The company's 1st funding round was a Series A of $1.4M, raised on Jun 01, 2009.
What does Biosyntech do?
BioSyntech was founded in 1994 in Laval, Canada, as a biotechnology firm. Chitosan-based hydrogels, known as BST-Gel, were developed for cartilage repair and therapeutic agent delivery. These thermogels, liquid at low temperatures and solid at body temperature, were designed for injection or application to sites like damaged cartilage, bone, and chronic wounds. Bankruptcy was filed in May 2010, followed by acquisition by Piramal Healthcare in June 2010.
Who are the top competitors of Biosyntech?
Biosyntech's top competitors include Ilya Pharma, AmacaThera and Augmenix.
Who are Biosyntech's investors?
Biosyntech has 5 investors. Key investors include Piramal Group, ProQuest Investments, Highland Capital Partners, Fonds de solidarite FTQ, and Pappas Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.